Taiwan Resonant Waves Research Corp. has been approved by Taiwan Food and Drug Administration (TFDA) to commence clinical trials.

  • trwrwriter
  • 2017-04-01

Our randomized, double-blind trial is underway at National Taiwan University Hospital, National Cheng Kung University Hospital, and two other medical facilities. Under the investigative leadership of 20 medical professionals, the study is expected to be completed in 2018 and potentially become the world’s first non-invasive electronic medical device used to alleviate symptoms associated with type 2 diabetes.

Contact us

+886-2-2729-5800

Copyright © 2017 Taiwan Resonant Waves Research Corp., All rights reserved.
Web Planning - Studio 2.5D